Antiviral agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9492501
APP PUB NO 20120035098A1
SERIAL NO

13254502

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes the use of a composition including or constituted by at least one element chosen from:

    a specific protein including or consisting of the amino acid sequence SEQ ID NO: 5, anda protein homologous to the specific protein,for the preparation of a medicament intended for the prevention or treatment of pathologies associated with a viral infection or an inflammation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75016 PARIS
UNIVERSITE DE STRASBOURG67000 STRASBOURG
UNIVERSITE DE LA MEDITERRANEE13007 MARSEILLE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chabriere, Eric Marseilles, FR 9 37
Elias, Mikael Florange, FR 6 0
Rohr, Olivier Miserey-Salines, FR 2 1
Schwartz, Christian Lingolsheim, FR 9 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 15, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00